Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRABECTEDIN vs TRALOKINUMAB-LDRM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRABECTEDIN vs TRALOKINUMAB-LDRM: Safety Overview

Metric TRABECTEDIN TRALOKINUMAB-LDRM
Total FAERS Reports 1,957 4,116
Deaths Reported 376 57
Death Rate 19.2% 1.4%
Hospitalizations 896 239
Average Patient Age 56.4 yrs 50.5 yrs
% Female Patients 66.0% 61.8%
FDA Approval Date Oct 23, 2015 N/A
Manufacturer Janssen Products, LP N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A